Will DAIA resolve the ambiguities of regulating in vitro clinical tests?
Are your Companion Diagnostic Partners Ready?
Why Diagnostics Have Trouble Finding Their Voice
Immunothrapy: Predicting response to targeted therapies and checkpoint inhibitors
The Dawn of Personalized Medicine: The Role of the Pharmacist
Preventative medicine: genetic screening of inherited diseases
Of mice and men: Strategies for humanization in preclinical immuno-oncology research
table of contents
Editors Notes
Field Notes
Will DAIA resolve the ambiguities of regulating in vitro clinical tests?
Are your Companion Diagnostic Partners Ready?
Why Diagnostics Have Trouble Finding Their Voice
Cognoscienti
Immunothrapy: Predicting response to targeted therapies and checkpoint inhibitors
The Dawn of Personalized Medicine: The Role of the Pharmacist
Precision Tools
Preventatie medicine: genetic screening of inherited diseases
Next-Generation-Sequencing Data for Mouse Models: Applications and analysis in context of a pre-clinical oncology drug development
Makingthe Shift from Technological Innovation to Operational Excellence: Delivering on the Promis Of Next-Generation Sequencing for Personalized Medicine
Snpshot
Of mice and men: Strategies for humanization in preclinical immuno-oncology research
Preparing for the New Possible: A Summar of the 14th Annual Personalized Medicine Conference at Harvard Medical School
Tweets
New post: Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling https://t.co/IH1Rwtrv4t, - Access to care remains a barrier to patients and caregivers across the globe. Join us November 17 as we introduce n… https://t.co/s7TDOhdU1U,
- Precision Medicine News November 12, 2020 - https://t.co/X3QJSaNSAF,